Interlinking potential therapy with botulinum neurotoxin-A and Parkinson's disease

A Wree, A Hawlitschka, C Holzmann, M Witt… - … and Management in …, 2020 - Elsevier
The predominant characteristic of Parkinson's disease is the loss of dopaminergic neurons
in the substantia nigra pars compacta and axonal degeneration of dopaminergic fibers in the …

[PDF][PDF] Interlinking potential therapy with botulinum neurotoxin-A and Parkinson's disease

A Wree, A Hawlitschka, C Holzmann, M Witt, J Kurth… - 2020 - researchgate.net
Parkinson's disease (PD) is characterized by a progressive axonal degeneration of
dopaminergic fibers, dopamine (DA) depletion in the striatum (caudate-putamen [CPu]), and …